Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 21, 2025 | Touchstone Sands Capital International Growth Equity Fund | 18.1% | 19.4% | 6273 JP, EVD GR, GALD SW, HEXAB SS, IMCD NA, LONN SW, MELI, ONON, PME AU, SE, SPOT, TSM, WEB SS | AI, Cloud, growth, Platforms | EVD GR SE 2330 TT SPOT MELI |
View | |
| 2025 Q2 | Jul 17, 2025 | Platinum International Brands Fund | 6.6% | - | GALD SW, IDXX, WING | Consumer Staples, global brands, Margins, Pricing Power, Resilience | The letter focuses on global consumer brands with pricing power, loyal customer bases, and resilient demand. Management highlights brand equity as a defense against inflation and economic volatility. Long-term returns are driven by reinvestment, global scale, and margin stability. | IDXX WING GALD SW |
View |
| 2024 Q2 | Jun 30, 2024 | Platinum International Brands Fund | -1.0% | - | GALD SW, ZTS | - | View | ||
| 2025 Q1 | Mar 31, 2025 | Platinum International Brands Fund | -6.0% | -6.0% | GALD SW | - | View | ||
| 2024 Q4 | Dec 31, 2024 | BlackRock Innovation And Growth Term Trust | 1.0% | - | AXON, FND, GALD SW, VRT | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Artisan Global Discovery | 2.7% | 16.1% | ANET, GALD SW, GXI GR, MNDY, MPWR, MTSI, NZM GR, ON, PSTG, SGE LN | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Platinum International Brands Fund | 12.0% | 21.0% | AS, BIRK, ELF, GALD SW, JD/ LN, ZTS | - | View | ||
| 2025 Q3 | Oct 20, 2025 | Sands Capital Global Growth Fund | -2.0% | 12.2% | AXON, CVNA, DXCM, GALD SW, GOOG, III LN, IMCD NA, ISRG, NFLX, NVDA, RGEN, SHOP, SIKA SW, TEAM, TSM | Artificial Intelligence, E-Commerce, Global Growth, healthcare, semiconductors | The fund emphasizes durable global growth from AI infrastructure, digital platforms, and healthcare innovation. NVIDIA, Alphabet, and TSMC lead performance as AI capital investment accelerates worldwide. Managers added new positions in Galderma and 3i Group to balance cyclical risk while maintaining exposure to long-term technology and consumer adoption trends. | TEAM DEXCOM INTU NFLX AXON GALD SHOP GOOGL NVDA |
View |
| 2025 Q3 | Oct 20, 2025 | Touchstone Sands Capital International Growth Equity Fund | -3.1% | 15.7% | 6098 JP, ADYEN NA, ARGX, CSU CN, EVD GR, GALD SW, HEX NO, III LN, MELI, NU, PDRB, SE, SHOP, SIKASW, TSM | Artificial Intelligence, E-Commerce, financials, Global Growth, healthcare | International holdings in Asia and Europe saw mixed results, but structural themes in e-commerce and financial innovation continued to drive growth. The funds core exposures include Shopify, MercadoLibre, and Taiwan Semiconductor as AI-related demand spreads globally. Healthcare names like Argenx and Galderma support steady earnings through innovation and margin expansion. | View | |
| 2025 Q3 | Oct 19, 2025 | Artisan International Fund | 5.0% | 34.0% | 079550 KS, 300750 CH, A012450 KS, BABA, CRH, GALD SW, TCEHY, UCB | aerospace, defense, Electrification, Energy Storage, financials | Electrification is a central theme driven by EV demand, AI power needs, and grid expansion, benefiting holdings like CATL and Korea Electric Power. Rising global defense budgets support companies such as Hanwha Aerospace and LIG Nex1. Financial holdings like UBS and Lloyds gain from restructuring, dividends, and buybacks amid steady capital markets. | 3750 HK 012450 KS UBSG SW UCB BB |
View |
| 2024 Q3 | Sep 30, 2024 | Artisan Global Discovery | 7.6% | 13.1% | 0SAN LN, 669 HK, ARGX, CWAN, ESTC, GALD SW, HUBB, NU, NZM GR, RYTM, TCOM, TREX, TTEK, WING | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2026 | Fund Letters | Brian A. Christiansen | Galderma Group AG | Health Care | Pharmaceuticals | Bull | Swiss Exchange | Aesthetics, dermatology, innovation, Margins, pharmaceuticals | View Pitch |
| Jan 24, 2026 | Fund Letters | David E. Levanson | Galderma Group AG | Health Care | Pharmaceuticals | Bull | Swiss Exchange | Aesthetics, biologics, dermatology, Prescriptions, Pricing | View Pitch |
| Jan 21, 2026 | Fund Letters | Tom Coutts | Galderma Group AG | Health Care | Pharmaceuticals | Bull | Swiss Exchange | Aesthetics, dermatology, growth, Launches, Validation | View Pitch |
| Jan 8, 2026 | Fund Letters | Nikola Dvornak | Galderma Group AG | Health Care | Pharmaceuticals | Bull | Swiss Exchange | Aesthetics, consumer, dermatology, growth, healthcare, Injectables | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||